Enanta Pharmaceuticals reported $6M in Trade Creditors for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Creditors Change
Amgen AMGN:US USD 1.2B 52M
Anika Therapeutics ANIK:US USD 8.35M 188K
Arrowhead Research ARWR:US USD 2.87M 3.03M
Biogen BIIB:US USD 383.2M 51.6M
Bristol Myers Squibb BMY:US USD 2.6B 287M
Clovis Oncology CLVS:US USD 18.12M 6.1M
Enanta Pharmaceuticals ENTA:US USD 6M 4.76M
Halozyme Therapeutics HALO:US USD 18.17M 5.93M
Heron Therapeutics HRTX:US USD 6.55M 7.26M
Insmed INSM:US USD 11.58M 19.57M
Intercept Pharmaceuticals ICPT:US USD 21.3M 9.64M
Karyopharm Therapeutics KPTI:US USD 813K 881K
Marinus Pharmaceuticals MRNS:US USD 1.62M 1.68M
Novartis NOVN:VX USD 4.69B 276M
Novavax NVAX:US USD 145M 241.49M
Ptc Therapeutics PTCT:US USD 20.86M 2.02M
Sarepta Therapeutics SRPT:US USD 118.46M 62.25M
Vertex Pharmaceuticals VRTX:US USD 126.9M 71.1M
Vital Therapies VTL:US USD 4.17M 55K
YTE INCY:US USD 163.17M 31.6M